Featured Press Releases

Orsini begins distribution of CASGEVY® (exagamglogene autotemcel), a gene-editing therapy

Orsini begins distribution of CASGEVY® (exagamglogene autotemcel), a gene-editing therapy

Cytonics Begins First-In-Human Phase 1 Clinical Study for CYT-108 in Osteoarthritis Knee Patients

Cytonics Begins First-In-Human Phase 1 Clinical Study for CYT-108 in Osteoarthritis Knee Patients

  • 15 Jul 2024

Cytonics Corporation, a private biotechnology company developing biologic therapies for...

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

Axion BioSystems extends its agreement with Corning®, granting exclusive rights to distribute its award-winning cell counting device.

Axion BioSystems extends its agreement with Corning®, granting exclusive rights to distribute its award-winning cell counting device.

Bristol Myers Squibb and Pfizer to provide Eliquis® (apixaban) through the Mark Cuban Cost Plus Drug Company

Bristol Myers Squibb and Pfizer to provide Eliquis® (apixaban) through the Mark Cuban Cost Plus Drug Company

BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

Alchemy 21/12 Introduces Oleotide™, a Breakthrough Modular Biotechnology Platform for Advanced Skincare

Alchemy 21/12 Introduces Oleotide™, a Breakthrough Modular Biotechnology Platform for Advanced Skincare

  • Alchemy 21/12
  • 28 Oct 2026
CELSET Launches Korean Botulinum Toxin Type A Brand SOLTOX in International Markets

CELSET Launches Korean Botulinum Toxin Type A Brand SOLTOX in International Markets

  • CELSET INC
  • 28 Oct 2026
SEKISUI Diagnostics Announces 510(k) Clearance and Launches the OSOM® COVID-19/Flu A&B Combo Test

SEKISUI Diagnostics Announces 510(k) Clearance and Launches the OSOM® COVID-19/Flu A&B Combo Test

  • SEKISUI DIAGNOSTICS, LLC
  • 27 Oct 2026
Stevanato Group and Aptar Pharma Collaborate to Accelerate Pre-Filled Syringe System Selection

Stevanato Group and Aptar Pharma Collaborate to Accelerate Pre-Filled Syringe System Selection

  • Stevanato Group S.p.A.
  • 27 Oct 2026
Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

  • Pythia Labs
  • 27 Oct 2026
Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

  • Pythia Labs
  • 27 Oct 2026

Most Popular
October   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.